216 related articles for article (PubMed ID: 20471394)
1. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
[TBL] [Abstract][Full Text] [Related]
2. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors.
Zhan L; Xiang B; Muthuswamy SK
Cancer Res; 2006 May; 66(10):5201-8. PubMed ID: 16707444
[TBL] [Abstract][Full Text] [Related]
3. [Bacterial synthesis, purification, and solubilization of transmembrane segments of ErbB family members].
Goncharuk MV; Shul'ga AA; Ermoliuk IaS; Tkach EN; Goncharuk SA; Pustovalova IuE; Mineev KS; Bocharov ÉV; Maslennikov IV; Arsen'ev AS; Kirpichnikov MP
Mol Biol (Mosk); 2011; 45(5):892-902. PubMed ID: 22393787
[TBL] [Abstract][Full Text] [Related]
4. The ErbB/HER receptor protein-tyrosine kinases and cancer.
Roskoski R
Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
[TBL] [Abstract][Full Text] [Related]
5. Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases.
Singh J; Dobrusin EM; Fry DW; Haske T; Whitty A; McNamara DJ
J Med Chem; 1997 Mar; 40(7):1130-5. PubMed ID: 9089334
[TBL] [Abstract][Full Text] [Related]
6. Two GxxxG-like motifs facilitate promiscuous interactions of the human ErbB transmembrane domains.
Escher C; Cymer F; Schneider D
J Mol Biol; 2009 May; 389(1):10-6. PubMed ID: 19361517
[TBL] [Abstract][Full Text] [Related]
7. Spatial structure of the dimeric transmembrane domain of the growth factor receptor ErbB2 presumably corresponding to the receptor active state.
Bocharov EV; Mineev KS; Volynsky PE; Ermolyuk YS; Tkach EN; Sobol AG; Chupin VV; Kirpichnikov MP; Efremov RG; Arseniev AS
J Biol Chem; 2008 Mar; 283(11):6950-6. PubMed ID: 18178548
[TBL] [Abstract][Full Text] [Related]
8. The transmembrane domains of ErbB receptors do not dimerize strongly in micelles.
Stanley AM; Fleming KG
J Mol Biol; 2005 Apr; 347(4):759-72. PubMed ID: 15769468
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics (MD) investigations of preformed structures of the transmembrane domain of the oncogenic Neu receptor dimer in a DMPC bilayer.
Aller P; Voiry L; Garnier N; Genest M
Biopolymers; 2005 Mar; 77(4):184-97. PubMed ID: 15660449
[TBL] [Abstract][Full Text] [Related]
10. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
Pinkas-Kramarski R; Soussan L; Waterman H; Levkowitz G; Alroy I; Klapper L; Lavi S; Seger R; Ratzkin BJ; Sela M; Yarden Y
EMBO J; 1996 May; 15(10):2452-67. PubMed ID: 8665853
[TBL] [Abstract][Full Text] [Related]
11. Systematic molecular dynamics searching in a lipid bilayer: application to the glycophorin A and oncogenic ErbB-2 transmembrane domains.
Beevers AJ; Kukol A
J Mol Graph Model; 2006 Oct; 25(2):226-33. PubMed ID: 16434222
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
13. Transmembrane helix packing of ErbB/Neu receptor in membrane environment: a molecular dynamics study.
Aller P; Garnier N; Genest M
J Biomol Struct Dyn; 2006 Dec; 24(3):209-28. PubMed ID: 17054379
[TBL] [Abstract][Full Text] [Related]
14. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
15. A putative mechanism for downregulation of the catalytic activity of the EGF receptor via direct contact between its kinase and C-terminal domains.
Landau M; Fleishman SJ; Ben-Tal N
Structure; 2004 Dec; 12(12):2265-75. PubMed ID: 15576039
[TBL] [Abstract][Full Text] [Related]
16. HER2 Transmembrane Domain Dimerization Coupled with Self-Association of Membrane-Embedded Cytoplasmic Juxtamembrane Regions.
Bragin PE; Mineev KS; Bocharova OV; Volynsky PE; Bocharov EV; Arseniev AS
J Mol Biol; 2016 Jan; 428(1):52-61. PubMed ID: 26585403
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor transmembrane domain: 2H NMR implications for orientation and motion in a bilayer environment.
Jones DH; Barber KR; VanDerLoo EW; Grant CW
Biochemistry; 1998 Nov; 37(47):16780-7. PubMed ID: 9843449
[TBL] [Abstract][Full Text] [Related]
18. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
Sajot N; Genest M
J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics simulations of the transmembrane domain of the oncogenic ErbB2 receptor dimer in a DMPC bilayer.
Garnier N; Crouzy S; Genest M
J Biomol Struct Dyn; 2003 Oct; 21(2):179-200. PubMed ID: 12956604
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
